News
Stay informed on the latest clinical milestones, media coverage, and partnerships from J3 Bioscience.
Explore how our IVR platform continues to drive new opportunities for hormone-free innovation in women’s health.
Consumers find LIV-Ring effectively addresses needs for vaginal dryness relief.
The findings demonstrate the effectiveness of LIV-Ring in addressing symptoms commonly associated with vaginal dryness – the second most common symptom of menopause – offering a meaningful new option to women seeking clinically tested, non-hormonal, and readily accessible solutions.
J3 Bioscience, Inc. appoints John Fair as new president & CEO.
J3 Bioscience, Inc., a commercialization stage startup medical device company focused on women’s health, today announced the appointment of John Fair as its new President and Chief Executive Officer, effective immediately. Founder and current CEO Tyler McCabe will transition to the role of Chief Operating Officer.
J3 Bioscience, Inc. announces appointment of new director to board
J3 Bioscience, Inc., a commercialization stage women’s health medical device company, today announced the appointment of Dr. Sheryl A. Kingsberg to its Board of Directors.